OBJECTIVE: To identify the risk factors associated with development of postoperative elevation of creatine kinase (CK) and study its effect on renal function in patients who underwent complex multifocal partial nephrectomy (PN). METHODS: Patients who underwent PN at National Cancer Institute between January 2007 and December 2012 were included in the study. Elevated serum CK was defined as >2000 U/L. Kidney function was assessed using serum creatinine and estimated glomerular filtration rate (eGFR). Changes were reported as percent change from preoperative values and compared using the Wilcoxon test. Regression analysis was performed to identify the predictors of elevation in CK and decline in eGFR. RESULTS: From 407 total cases, 207 had adequate CK data for analysis. Median number of tumors removed was 3 (1-70). Median peak CK was 1458 (82-36,788). Forty-two percent developed CK elevation >2000 U/L. Factors associated with postoperative elevation of CK > 2000 were young age (p = 0.009), high BMI (p = 0.003) and operating room time (p < 0.001). Although CK > 2000 was associated with significantly greater decline in eGFR (37.4 vs. 20.3 %, p < 0.001) in immediate postoperative period, this change largely resolved to a much less clinically relevant (9.2 vs 3.3 %, p = 0.040) change after 3 months. On multivariate analysis, postoperative elevation in CK was not found to be an independent factor determining renal function at 3 months. CONCLUSION: In our cohort, a significant proportion of patients developed CK elevations >2000 U/L. While patients with elevated CK had more decline in eGFR in immediate postoperative period, postoperative elevations of CK did not appear to impact overall long-term renal function in patients undergoing PN.
OBJECTIVE: To identify the risk factors associated with development of postoperative elevation of creatine kinase (CK) and study its effect on renal function in patients who underwent complex multifocal partial nephrectomy (PN). METHODS:Patients who underwent PN at National Cancer Institute between January 2007 and December 2012 were included in the study. Elevated serum CK was defined as >2000 U/L. Kidney function was assessed using serum creatinine and estimated glomerular filtration rate (eGFR). Changes were reported as percent change from preoperative values and compared using the Wilcoxon test. Regression analysis was performed to identify the predictors of elevation in CK and decline in eGFR. RESULTS: From 407 total cases, 207 had adequate CK data for analysis. Median number of tumors removed was 3 (1-70). Median peak CK was 1458 (82-36,788). Forty-two percent developed CK elevation >2000 U/L. Factors associated with postoperative elevation of CK > 2000 were young age (p = 0.009), high BMI (p = 0.003) and operating room time (p < 0.001). Although CK > 2000 was associated with significantly greater decline in eGFR (37.4 vs. 20.3 %, p < 0.001) in immediate postoperative period, this change largely resolved to a much less clinically relevant (9.2 vs 3.3 %, p = 0.040) change after 3 months. On multivariate analysis, postoperative elevation in CK was not found to be an independent factor determining renal function at 3 months. CONCLUSION: In our cohort, a significant proportion of patients developed CK elevations >2000 U/L. While patients with elevated CK had more decline in eGFR in immediate postoperative period, postoperative elevations of CK did not appear to impact overall long-term renal function in patients undergoing PN.
Authors: Francisco Gelpi-Hammerschmidt; Ilker Tinay; Christopher B Allard; Li-Ming Su; Mark A Preston; Quoc-Dien Trinh; Adam S Kibel; Ye Wang; Benjamin I Chung; Steven L Chang Journal: J Urol Date: 2015-08-28 Impact factor: 7.450
Authors: Claudio Jeldres; Karim Bensalah; Umberto Capitanio; Laurent Zini; Paul Perrotte; Nazareno Suardi; Jacques Tostain; Antoine Valeri; Jean-Luc Descotes; Jean-Jacques Rambeaud; Alexandre de La Taille; Laurent Salomon; Claude Abbou; Jean-Jacques Patard; Pierre I Karakiewicz Journal: BJU Int Date: 2009-06 Impact factor: 5.588
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Matthew J Watson; Abhinav Sidana; Eric A Singer; Gopal N Gupta; Ardeshir R Rastinehad; Srinivas Vourganti; Gennady Bratslavsky; Adam R Metwalli Journal: Int Urol Nephrol Date: 2016-10-27 Impact factor: 2.370
Authors: Matthew J Watson; Abhinav Sidana; Annerleim Walton Diaz; M Minhaj Siddiqui; Ryan A Hankins; Gennady Bratslavsky; W Marston Linehan; Adam R Metwalli Journal: J Endourol Date: 2016-10-20 Impact factor: 2.942